Preferential recognition of hydroxyl radical-modified superoxide dismutase by circulating autoantibodies in patients with alopecia areata

Annals of Dermatology

Volumn 26, Issue 5, 2014, Pages 576-583

  Alzolibani, Abdullateef A ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Alopecia areata; Autoimmunity; Reactive oxygen species; Superoxide dismutase; OH SOD

Indexed keywords

EID: 84907618358     PISSN: 10139087     EISSN: 20053894     Source Type: Journal    
DOI: 10.5021/ad.2014.26.5.576     Document Type: Article

References (33)

1. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;(2):CD004413.
2. Alkhalifah A. Alopecia areata update. Dermatol Clin 2013;31:93-108.
3. Bertolini M, Gilhar A, Paus R. Alopecia areata as a model for T cell-dependent autoimmune diseases. Exp Dermatol 2012;21:477-479.
4. Seetharam KA. Alopecia areata: an update. Indian J Dermatol Venereol Leprol 2013;79:563-575.
5. Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol 2008;53:70-74.
6. Hordinsky M, Ericson M. Autoimmunity: alopecia areata. J Investig Dermatol Symp Proc 2004;9:73-78.
7. Kim SW, Kim BJ, Youn SW, Park KC, Huh CH. Evaluation of free oxygen radical and antioxidant capacity in alopecia areata. J Dermatol 2010;37:762-764.
8. Abdel Fattah NS, Ebrahim AA, El Okda ES. Lipid peroxidation/antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol 2011;25:403-408.
9. Akar A, Arca E, Erbil H, Akay C, Sayal A, Gür AR. Anti-oxidant enzymes and lipid peroxidation in the scalp of patients with alopecia areata. J Dermatol Sci 2002;29:85-90.
10. Bilgili SG, Ozkol H, Karadag AS, Ozkol HU, Seker A, Calka O, et al. Serum paraoxonase activity and oxidative status in subjects with alopecia areata. Cutan Ocul Toxicol 2013;32:290-293.
11. Al-Shobaili HA, Alzolibani AA, Al Robaee AA, Meki AR, Rasheed Z. Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity. J Clin Lab Anal 2013;27:45-52.
12. Rasheed Z, Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Wadi WI, Khan MI, et al. Preferential recognition of peroxynitrite damaged thymidine-monophosphate by anti-DNA autoantibodies in systemic lupus erythematosus. Nucleosides Nucleotides Nucleic Acids 2012;31:736-751.
13. Bakry OA, Elshazly RM, Shoeib MA, Gooda A. Oxidative stress in alopecia areata: a case-control study. Am J Clin Dermatol 2014;15:57-64.
14. Namazi MR. Nitric oxide donors as potential additions to anti-alopecia areata armamentarium. Inflamm Res 2003;52:227-229.
15. Koca R, Armutcu F, Altinyazar C, Gürel A. Evaluation of lipid peroxidation, oxidant/antioxidant status, and serum nitric oxide levels in alopecia areata. Med Sci Monit 2005;11:CR296-CR299.
16. Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers 2012;33:19-34.
17. Rasheed Z, Ahmad R, Rasheed N, Ali R. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma. J Exp Clin Cancer Res 2007;26:395-404.
18. Rasheed Z, Ahmad R, Rasheed N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 2007;40:512-520.
19. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 2009;29:309-318.
20. Al-Shobaili HA, Rasheed Z. Immunological studies of oxidized superoxide dismutase in patients with systemic lupus erythematosus. Correlation with disease induction and progression. Saudi Med J 2012;33:1177-1184.
21. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999;40:242-246.
22. Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies. Clin Biochem 2008;41:663-669.
23. Goding JW. Use of staphylococcal protein A as an immunological reagent. J Immunol Methods 1978;20:241-253.
24. Alzolibani AA, Al Robaee AA, Al-Shobaili HA, Rasheed Z. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell Immunol 2013;284:154-162.
25. Rasheed Z, Al-Shobaili HA, Alzolibani AA, Ismail Khan M, Tariq Ayub M, Khan MI, et al. Immunological functions of oxidized human immunoglobulin G in type 1diabetes mellitus: its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis Markers 2011;31:47-54.
26. Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index. Immunol Invest 2013;42:191-203.
27. Rasheed Z, Ali R. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Life Sci 2006;79:2320-2328.
28. Rasheed Z, Ahmad R, Ali R. Structure and immunological function of oxidised albumin in lung cancer: its potential role as a biomarker of elevated oxidative stress. Br J Biomed Sci 2009;66:67-73.
29. Kutner A, Friedman A. Hair loss in the dermatology office: an update on alopecia areata. J Drugs Dermatol 2013;12:588-593.
30. Tosti A, Duque-Estrada B. Treatment strategies for alopecia. Expert Opin Pharmacother 2009;10:1017-1026.
31. Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct 2000;18:169-173.
32. Batinić-Haberle I, Rebouc¸as JS, Spasojević I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 2010;13:877-918.
33. Johnson F, Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005;26:340-352.